Kumamoto University launches academic venture 'Kumadai Research Institute' to boost semiconductor management ecosystem
Business Announcement
Updates every hour. Last Updated: 30-Oct-2026 22:16 ET (31-Oct-2026 02:16 GMT/UTC)
- A Cambridge-led team has developed a way to engineer better vaccines that could provide broad protection from thousands of variants of viruses - such as coronaviruses or Ebola - in a single vaccine.
- This represents a fundamental new vaccine technology that could prevent future pandemics before they begin.
- The team used the technology to engineer a vaccine designed to protect against a wide range of coronaviruses, including the cause of the COVID pandemic.
- The results of the first-in-human clinical trial of this technology found it is safe and well tolerated.